Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
First-line treatment with nivolumab plus ipilimumab resulted in a longer duration of overall survival than did chemotherapy in patients with NSCLC, independent of the PD-L1 expr...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 2,696
- Institution
- Hospital Universitario Virgen del Rocío
External Links
Identifiers
- ORCID
- 0000-0003-0312-9195
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.